This event has passed.

How does a Novel Food get to your plate?

Name: How does a Novel Food get to your plate?
Start: 2024-09-30T14:00:00+02:00
End: 2024-09-30T16:00:00+02:00

30 September 2024 @ 2:00 pm – 4:00 pm CEST

This EuropaBio’s webinar will focus on the pathway to market for Novel Foods, from initial development in R&D through to consumer uptake while going through risk assessment and approval. Each speaker will cover a key point along the value chain, including illustrative examples and case studies where relevant.

The event will be moderated by Hannah Lester, CEO at Atova Consulting.

The confirmed speakers are:

Muriel Dewilde, Business Development Manager, Bio Base Europe Pilot Plant
Ermolaos Ververis, Scientific Officer Nutrition & Food Innovation Unit, EFSA
Timen Van Haaster, Public Affairs & Communications Director, HollandBio
Anders Nelving, Line Solution Manager, Tetra Pak
Per Falholt, CSO at 21st Bio

EuropaBio

Event Navigation

Algal Omega 3

Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

Cheese

Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.

Clothes

Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

Vitamin B2

The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

Detergents

Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

Insulin

Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.